Clinical Trial Update: Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating a combination of selinexor, carfilzomib, isatuximab, and dexamethasone in relapsed or refractory multiple myeloma. The study is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (Kyprolis) (carfilzomib)
• DEXAMETHASONE (Dexamethasone)
• Isatuximab (Sarclisa) (isatuximab)
• Selinexor (Xpovio) (Selinexor)

Snippet

Sponsor: Natalie Callander | Conditions: Relapse Multiple Myeloma, Refractory Multiple Myeloma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING